Results 161 to 170 of about 501,302 (307)

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Abortion in conflict zones: moral responsibilities of humanitarian agencies in providing safe abortion care. [PDF]

Front Reprod Health
Anokwuru CC, Ekwebene OC, Nwuzoh MI, Edeh GC, Nwalieji CA, Udokang EI, Obi CG, Eneh S.   +7 more
europepmc   +1 more source

Humanitarian mapping [PDF]

Forced Migration Review, 2003
Rupert Douglas-Bate
doaj  

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Co-creating a decision-making framework for primary healthcare models in conflict-affected Cameroon and Nigeria. [PDF]

BMJ Glob Health
Omam LA, Alain M, Wudiri Z, Moustapha CA, Nuraini A, Asimiya SS, O'Laughlin KN, Ambebe R, Alfred J, Jarman E, Martin S, Njingu AE, Musa I, Fuen FM, Choupo L, Andu L, Manuel S, Acha-Morfaw O, Fuh CE, Nicholas T, Idrissou M, Mohammed H, Van Bortel T, Parkes-Ratanshi R.   +23 more
europepmc   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Trauma Systems in Conflict Zones: A Qualitative Study of Field Operational Requirements in Humanitarian Care. [PDF]

World J Surg
Markou-Pappas N, Ansaloni L, Ragazzoni L, Barone-Adesi F, Lamine H.   +4 more
europepmc   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Women's perceptions of person-centered comprehensive abortion care and associated factors in Northern Ethiopia: a facility-based cross-sectional study in a humanitarian setting. [PDF]

Confl Health
Amare NS, Seyoum T, Tariku A, Mattison C, Allvin MK.   +4 more
europepmc   +1 more source